Bergen Laleli Koc
Research Subjects
Research Interests
Bergen Laleli Koc has a total of 93 co-authors. Here are the top co-authors by number of shared publications:
- Dilek Sahin
Perinatology Department Ankara Bilkent City Hospital Ankara Turkey
10 shared publications - Duygu Tugrul Ersak
Department of Perinatology, Ankara Bilkent City Hospital, Ankara, Turkey
9 shared publications - Özgür Kara
Department of Perinatalogy Ankara Bilkent City Hospital Ankara Turkey
8 shared publications - Atakan Tanacan
Perinatology Department Ankara Bilkent City Hospital Ankara Turkey
5 shared publications - Burak Elmas
Department of Obstetrics and Gynecology Ankara Bilkent City Hospital Ankara Turkey
5 shared publications - Burcu Timur
Department of Obstetrics and Gynecology, Ordu University Training and Research Hospital, Ordu, Turkey
5 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 72 (2) , e20251351
The relationship of soluble urokinase plasminogen activator receptor levels with preterm premature rupture of membranes and predictive value in neonatal intensive care unit admission
SUMMARY OBJECTIVE: Preterm premature rupture of membranes is a pregnancy complication in which infection and inflammation play an important role. Soluble urokinase plasminogen activator receptor has been described as a biomarker of infectious and inflammatory diseases. The aim of this study was to evaluate maternal serum soluble urokinase plasminogen activator receptor levels in pregnant women with preterm premature rupture of membranes and to determine the predictive value in neonatal outcomes. METHODS: In this prospective case-control study, complete blood count parameters, serum C-reactive protein, and soluble urokinase plasminogen activator receptor levels of 40 pregnant women with preterm premature rupture of membranes and 40 randomly selected healthy pregnant women between 22 and 34 weeks’ gestation were recorded. Neutrophil-to-lymphocyte ratio, systemic inflammation response index, and systemic immune-inflammation index were calculated. Receiver operating characteristic analysis assessed the predictive value of maternal serum soluble urokinase plasminogen activator receptor levels for neonatal intensive care unit admission. RESULTS: Maternal serum soluble urokinase plasminogen activator receptor levels, neutrophil-to-lymphocyte ratio, systemic immune-inflammation index, and systemic inflammation response index scores were significantly higher in the preterm premature rupture of membranes group than in controls (p<0.05). The soluble urokinase plasminogen activator receptor value in receiver operating characteristic analysis identified 4.33 ng/mL (62% sensitivity, 64% specificity) and 3.65 ng/mL (72% sensitivity, 73% specificity) for neonatal intensive care unit admission and adverse perinatal outcomes in the preterm premature rupture of membranes group (p<0.05). CONCLUSION: Soluble urokinase plasminogen activator receptor may be used as an ancillary marker in the prediction of neonatal intensive care unit admission and adverse perinatal outcome in preterm premature rupture of membranes cases, along with clinical findings.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 72 (2) , e20251351
Open AccessThe relationship of soluble urokinase plasminogen activator receptor levels with preterm premature rupture of membranes and predictive value in neonatal intensive care unit admission
SUMMARY OBJECTIVE: Preterm premature rupture of membranes is a pregnancy complication in which infection and inflammation play an important role. Soluble urokinase plasminogen activator receptor has been described as a biomarker of infectious and inflammatory diseases. The aim of this study was to evaluate maternal serum soluble urokinase plasminogen activator receptor levels in pregnant women with preterm premature rupture of membranes and to determine the predictive value in neonatal outcomes. METHODS: In this prospective case-control study, complete blood count parameters, serum C-reactive protein, and soluble urokinase plasminogen activator receptor levels of 40 pregnant women with preterm premature rupture of membranes and 40 randomly selected healthy pregnant women between 22 and 34 weeks’ gestation were recorded. Neutrophil-to-lymphocyte ratio, systemic inflammation response index, and systemic immune-inflammation index were calculated. Receiver operating characteristic analysis assessed the predictive value of maternal serum soluble urokinase plasminogen activator receptor levels for neonatal intensive care unit admission. RESULTS: Maternal serum soluble urokinase plasminogen activator receptor levels, neutrophil-to-lymphocyte ratio, systemic immune-inflammation index, and systemic inflammation response index scores were significantly higher in the preterm premature rupture of membranes group than in controls (p<0.05). The soluble urokinase plasminogen activator receptor value in receiver operating characteristic analysis identified 4.33 ng/mL (62% sensitivity, 64% specificity) and 3.65 ng/mL (72% sensitivity, 73% specificity) for neonatal intensive care unit admission and adverse perinatal outcomes in the preterm premature rupture of membranes group (p<0.05). CONCLUSION: Soluble urokinase plasminogen activator receptor may be used as an ancillary marker in the prediction of neonatal intensive care unit admission and adverse perinatal outcome in preterm premature rupture of membranes cases, along with clinical findings.
- 20 February 2025
- Published by Wiley in Journal of Clinical Ultrasound
- Vol. 53 (4) , 785-791
Ultrasonographic Evaluation of the Fetal Thymic‐Thoracic Ratio in Pregnant Women With Asthma
Purpose: To investigate the thymic‐thoracic ratio (TTR) in pregnant women with asthma to determine whether fetal thymus size is affected in this condition.Methods: A total of 139 patients, 69 patients diagnosed with asthma and 70 controls were prospectively included in the study at a single tertiary center. Eighteen of the patients diagnosed with asthma experienced at least one asthma attack, while 51 patients did not have any asthma attacks during pregnancy. TTR was calculated from the anterior‐posterior dimensions of the thymus and intrathoracic mediastinal measurements.Results: TTR was found to be statistically significantly lower in patients with asthma compared to the controls (p < 0.001). The rate of neonatal intensive care unit admission was higher and the TTR value was lower among the cases presenting with an asthma attack during pregnancy compared to patients without asthma attack and controls (p = 0.043 and p = 0.001, respectively). A statistical difference was found between patients with and without asthma attacks regarding the use of medication for asthma (p < 0.05).Conclusion: The fetal thymus has been found to be affected in patients with asthma. The TTR is lower in patients who have asthma attacks during pregnancy and in patients taking medication for treatment, which may be related to chronic inflammatory process as well as to the use of exogenous steroids.
- 20 February 2025
- Published by Wiley in Journal of Clinical Ultrasound
- Vol. 53 (4) , 785-791
Ultrasonographic Evaluation of the Fetal Thymic‐Thoracic Ratio in Pregnant Women With Asthma
Purpose: To investigate the thymic‐thoracic ratio (TTR) in pregnant women with asthma to determine whether fetal thymus size is affected in this condition.Methods: A total of 139 patients, 69 patients diagnosed with asthma and 70 controls were prospectively included in the study at a single tertiary center. Eighteen of the patients diagnosed with asthma experienced at least one asthma attack, while 51 patients did not have any asthma attacks during pregnancy. TTR was calculated from the anterior‐posterior dimensions of the thymus and intrathoracic mediastinal measurements.Results: TTR was found to be statistically significantly lower in patients with asthma compared to the controls (p < 0.001). The rate of neonatal intensive care unit admission was higher and the TTR value was lower among the cases presenting with an asthma attack during pregnancy compared to patients without asthma attack and controls (p = 0.043 and p = 0.001, respectively). A statistical difference was found between patients with and without asthma attacks regarding the use of medication for asthma (p < 0.05).Conclusion: The fetal thymus has been found to be affected in patients with asthma. The TTR is lower in patients who have asthma attacks during pregnancy and in patients taking medication for treatment, which may be related to chronic inflammatory process as well as to the use of exogenous steroids.
- Open Access
- 31 October 2024
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 24 (1) , 1-7
Comparison of two different suction curettage methods in cesarean scar pregnancy treatment
Background: Cesarean scar pregnancy (CSP), the incidence of which is increasing, can lead to life-threatening consequences. In this study, it was aimed to compare the results of two different ultrasound-assisted suction curettage (SC) approaches that we applied to endogenous type CSPs in different time periods. Methods: Patients who were diagnosed with CSP and treated with SC in the early pregnancy service between January 2012 and March 2019 were included in the study. While classical SC was applied until December 2016, patients were treated with SC modified by us after this date. Demographic characteristics, preoperative clinical findings, intraoperative characteristics and postoperative short-term follow-up of these two groups of patients belonging to different time periods were compared. Results: 34 patients were treated with classic SC (Group 1) and 32 patients with modified SC (Group 2). The amount of decrease in Hemoglobin values measured at the sixth hour postoperatively compared to the preoperative period was found to be less in group 2 (1.01 ± 0.67 g/dl) than in group 1 (1.39 ± 0.85 g/dl) (p = 0.042). The treatment failure rate was found to be lower in group 2 (p = 0.028). According to the results of multiple logistic regression analysis of significant factors associated with treatment outcome, myometrial thickness measurement and the largest gestational diameter measurement were found to be significant independent factors. Conclusion: In CSP cases, SC procedure with abdominal ultrasonography is an effective and reliable approach. At the beginning of this surgical procedure, if the gestational sac is removed from the uterine wall with the curettage cannula before suction, the success of the procedure will increase even more.
- 31 October 2024
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 24 (1) , 1-7
Open AccessComparison of two different suction curettage methods in cesarean scar pregnancy treatment
Background: Cesarean scar pregnancy (CSP), the incidence of which is increasing, can lead to life-threatening consequences. In this study, it was aimed to compare the results of two different ultrasound-assisted suction curettage (SC) approaches that we applied to endogenous type CSPs in different time periods. Methods: Patients who were diagnosed with CSP and treated with SC in the early pregnancy service between January 2012 and March 2019 were included in the study. While classical SC was applied until December 2016, patients were treated with SC modified by us after this date. Demographic characteristics, preoperative clinical findings, intraoperative characteristics and postoperative short-term follow-up of these two groups of patients belonging to different time periods were compared. Results: 34 patients were treated with classic SC (Group 1) and 32 patients with modified SC (Group 2). The amount of decrease in Hemoglobin values measured at the sixth hour postoperatively compared to the preoperative period was found to be less in group 2 (1.01 ± 0.67 g/dl) than in group 1 (1.39 ± 0.85 g/dl) (p = 0.042). The treatment failure rate was found to be lower in group 2 (p = 0.028). According to the results of multiple logistic regression analysis of significant factors associated with treatment outcome, myometrial thickness measurement and the largest gestational diameter measurement were found to be significant independent factors. Conclusion: In CSP cases, SC procedure with abdominal ultrasonography is an effective and reliable approach. At the beginning of this surgical procedure, if the gestational sac is removed from the uterine wall with the curettage cannula before suction, the success of the procedure will increase even more.
- 1 October 2023
- Published by Ministry of Health, Ankara City Hospital in Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi
- Vol. 20 (3) , 1888-1893
Evaluation of maternal anxiety and depression levels in pregnancies with fetal anomalies
Aim: This study aimed to document depression and anxiety levels in pregnant women with intrauterine fetal anomalies based on objective measurement inventories, raise awareness of this issue and provide the necessary support to patients. Materials and Method: Forty pregnant women between the ages of 18-41 who were diagnosed with a major fetal anomaly, and decided their pregnancy to continue were included in the study group. Forty pregnant women with a healthy fetus and gestational week and maternal age matched with the study group were included as the control group. The Beck Depression Inventory (BDI) and the Spielberger State-Trait Anxiety Inventory (STAI) were applied to pregnant women. Results: Anxiety and depression levels were compared between pregnant women diagnosed with an intrauterine fetal anomaly and the control group. The mean BDI score was significantly higher in the study group (P=0.008). In the STAI scoring, the mean state anxiety level (P0.001) and the mean trait anxiety score (P=0.001) were found to be statistically higher in the study group compared to the control group. Conclusion: The depressive symptom scores and the state and trait anxiety levels of pregnant women with the intrauterine fetal anomaly, increased compared to the healthy pregnant women. These pregnant women should be provided with professional psychological support and necessary medical assistance during this difficult period.
- 1 October 2023
- Published by Ministry of Health, Ankara City Hospital in Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi
- Vol. 20 (3) , 1888-1893
Evaluation of maternal anxiety and depression levels in pregnancies with fetal anomalies
Aim: This study aimed to document depression and anxiety levels in pregnant women with intrauterine fetal anomalies based on objective measurement inventories, raise awareness of this issue and provide the necessary support to patients. Materials and Method: Forty pregnant women between the ages of 18-41 who were diagnosed with a major fetal anomaly, and decided their pregnancy to continue were included in the study group. Forty pregnant women with a healthy fetus and gestational week and maternal age matched with the study group were included as the control group. The Beck Depression Inventory (BDI) and the Spielberger State-Trait Anxiety Inventory (STAI) were applied to pregnant women. Results: Anxiety and depression levels were compared between pregnant women diagnosed with an intrauterine fetal anomaly and the control group. The mean BDI score was significantly higher in the study group (P=0.008). In the STAI scoring, the mean state anxiety level (P0.001) and the mean trait anxiety score (P=0.001) were found to be statistically higher in the study group compared to the control group. Conclusion: The depressive symptom scores and the state and trait anxiety levels of pregnant women with the intrauterine fetal anomaly, increased compared to the healthy pregnant women. These pregnant women should be provided with professional psychological support and necessary medical assistance during this difficult period.
- 1 September 2023
- Published by Galenos Yayinevi in Archives Of Epilepsy
- Vol. 29 (3) , 79-82
Changes in the Maternal Serum Inflammatory Parameters of Pregnant Women with Epilepsy
- 1 September 2023
- Published by Galenos Yayinevi in Archives Of Epilepsy
- Vol. 29 (3) , 79-82
Changes in the Maternal Serum Inflammatory Parameters of Pregnant Women with Epilepsy
- 2 July 2023
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 49 (9) , 2310-2316
Is maternal serum endocan level a novel marker in gestational diabetes mellitus?
Aim: To determine whether there was a significant difference between serum endocan levels of pregnant women with and without gestational diabetes mellitus (GDM). Methods: A total of 90 pregnant women, 45 with gestational diabetes and 45 healthy pregnant women, between 24 and 28 gestational weeks, were included in this prospective case-control study. The pregnant women were screened for gestational diabetes using a two-step protocol. Serum endocan levels were measured using a commercially available enzyme-linked immunosorbent assay (ELISA) kit. A p-value of <0.05 was considered statistically significant. Results: Serum endocan level was significantly higher in the GDM group than in healthy controls (168.46 +/- 160.6 vs. 105.66 +/- 26.52 pg/mL, respectively; p < 0.001). Serum endocan concentrations were positively correlated with the results of 50 g oral glucose challenge test (GCT) (p < 0.001). Receiver operating characteristic curve analysis showed that endocan with a cut-off point of 133.9 ng/dL indicated women with GDM with a sensitivity of 55.6% and specificity of 88.9% (area under the curve [AUC]: 0.737, 95% CI: 0.634-0.824). The overall differential performance of endocan according to the GDM groups was determined as 73.7% (p < 0.001). Maternal serum endocan level was positively correlated with fasting glucose, postprandial glucose, and glycated hemoglobin (HbA1c) (p < 0.001). Conclusions: Elevated endocan levels in gestational diabetes were correlated with fasting glucose, postprandial glucose, HbA1c, and oral glucose tolerance test (OGTT) results. Despite the low sensitivity of 55.6% and the high specificity of 88.9%, we found a high differential performance rate indicating that serum endocan levels were important for the pathophysiology of GDM and should be investigated for the possibility of being a novel marker in larger populations.
- 2 July 2023
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 49 (9) , 2310-2316
Is maternal serum endocan level a novel marker in gestational diabetes mellitus?
Aim: To determine whether there was a significant difference between serum endocan levels of pregnant women with and without gestational diabetes mellitus (GDM). Methods: A total of 90 pregnant women, 45 with gestational diabetes and 45 healthy pregnant women, between 24 and 28 gestational weeks, were included in this prospective case-control study. The pregnant women were screened for gestational diabetes using a two-step protocol. Serum endocan levels were measured using a commercially available enzyme-linked immunosorbent assay (ELISA) kit. A p-value of <0.05 was considered statistically significant. Results: Serum endocan level was significantly higher in the GDM group than in healthy controls (168.46 +/- 160.6 vs. 105.66 +/- 26.52 pg/mL, respectively; p < 0.001). Serum endocan concentrations were positively correlated with the results of 50 g oral glucose challenge test (GCT) (p < 0.001). Receiver operating characteristic curve analysis showed that endocan with a cut-off point of 133.9 ng/dL indicated women with GDM with a sensitivity of 55.6% and specificity of 88.9% (area under the curve [AUC]: 0.737, 95% CI: 0.634-0.824). The overall differential performance of endocan according to the GDM groups was determined as 73.7% (p < 0.001). Maternal serum endocan level was positively correlated with fasting glucose, postprandial glucose, and glycated hemoglobin (HbA1c) (p < 0.001). Conclusions: Elevated endocan levels in gestational diabetes were correlated with fasting glucose, postprandial glucose, HbA1c, and oral glucose tolerance test (OGTT) results. Despite the low sensitivity of 55.6% and the high specificity of 88.9%, we found a high differential performance rate indicating that serum endocan levels were important for the pathophysiology of GDM and should be investigated for the possibility of being a novel marker in larger populations.
- 3 May 2023
- Published by Wiley in Echocardiography
- Vol. 40 (6) , 500-506
Assessment of fetal cardiac functions in pregnant women with asthma
Aim: This study aims to investigate the effects of maternal asthma on fetal cardiac functions.Methods: The study was planned with 30 pregnant women who presented to a tertiary health center and were diagnosed with asthma and 60 healthy controls with similar gestational ages. The fetal echocardiographic assessment was assessed between 33 and 35 weeks of gestation with pulsed‐wave Doppler (PW), M‐mode, and tissue Doppler imaging (TDI). Fetal cardiac functions were compared between maternal asthma and the control group. Cardiac functions were assessed according to the duration of maternal asthma diagnosis, as well.Results: Early diastolic function parameters, tricuspid E wave (p = .001), and tricuspid E/A ratio (p = .005) were significantly lower in the group with maternal asthma. Tricuspid annular plane systolic excursion (TAPSE) and measurements of mitral annular plane systolic excursion (MAPSE) values were statistically lower in the study group than in the control group; p = .010 and p = .012, respectively. Parameters assessed with TDI (E′, A′, S′, E/E′, and MPI′ of tricuspid valves) and global cardiac function parameters assessed with PW like myocardial performance index (MPI) and left cardiac output (LCO) were similar between groups (p > .05). Although, MPI did not change between groups, and the isovolumetric relaxation time (IVRT) value was prolonged in maternal asthma cases (p = .025).Conclusion: We found that maternal asthma disease causes alteration in fetal diastolic and early systolic cardiac functions, but the global fetal cardiac function does not change. Diastolic heart function values also varied with the duration of maternal asthma. Prospective studies are needed to compare fetal cardiac functions with additional patient groups according to disease severity and type of medical treatment.
- 3 May 2023
- Published by Wiley in Echocardiography
- Vol. 40 (6) , 500-506
Assessment of fetal cardiac functions in pregnant women with asthma
Aim: This study aims to investigate the effects of maternal asthma on fetal cardiac functions.Methods: The study was planned with 30 pregnant women who presented to a tertiary health center and were diagnosed with asthma and 60 healthy controls with similar gestational ages. The fetal echocardiographic assessment was assessed between 33 and 35 weeks of gestation with pulsed‐wave Doppler (PW), M‐mode, and tissue Doppler imaging (TDI). Fetal cardiac functions were compared between maternal asthma and the control group. Cardiac functions were assessed according to the duration of maternal asthma diagnosis, as well.Results: Early diastolic function parameters, tricuspid E wave (p = .001), and tricuspid E/A ratio (p = .005) were significantly lower in the group with maternal asthma. Tricuspid annular plane systolic excursion (TAPSE) and measurements of mitral annular plane systolic excursion (MAPSE) values were statistically lower in the study group than in the control group; p = .010 and p = .012, respectively. Parameters assessed with TDI (E′, A′, S′, E/E′, and MPI′ of tricuspid valves) and global cardiac function parameters assessed with PW like myocardial performance index (MPI) and left cardiac output (LCO) were similar between groups (p > .05). Although, MPI did not change between groups, and the isovolumetric relaxation time (IVRT) value was prolonged in maternal asthma cases (p = .025).Conclusion: We found that maternal asthma disease causes alteration in fetal diastolic and early systolic cardiac functions, but the global fetal cardiac function does not change. Diastolic heart function values also varied with the duration of maternal asthma. Prospective studies are needed to compare fetal cardiac functions with additional patient groups according to disease severity and type of medical treatment.
- 30 March 2023
- Published by Ministry of Health, Ankara City Hospital in Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi
- Vol. 20 (1) , 1612-1616
Evaluation of placental pathologies in cases of placenta previa
Objective: The primary aim of our study was to evaluate the underlying placental pathologies of placenta previa (PP). Materials and Methods: Over two years data of patients diagnosed to be PP in a tertiary center were obtained retrospectively. Routinely, the placentas of patients diagnosed to be PP were sent for pathological examination. Clinicodemographic data of the patients were recorded. The placental pathological findings were classified and evaluated in 5 main groups: maternal vascular lesions, fetal vascular lesions, inflammatory situations, umbilical cord findings, and normal. Additionally, complete blood count results at admission time for hospitalization and the outcomes of the neonates were recorded. Results: Thirty-two patients diagnosed to be PP were included in the study. The median age was 34 (22-42), and the median gravidity number was 3 (1-6). Maternal vascular lesions were observed in nearly half of the PP patients as a pathological finding (43.75 %). Inflammation was observed in 10 patients (31.25 %), umbilical cord findings in 8 patients (25.0 %), and fetal vascular lesions in 2 patients (6.25 %), respectively. 3 patients were reported to have normal placentas. In addition, the median neutrophile, neutrophile lymphocyte ratio, and white blood count were found to be high at admission time for hospitalization Conclusion: Maternal vascular lesions and inflammation were the most common detected placental pathological reports in PP patients. However, studies including the placentas of uncomplicated pregnancies will shed light on the literature to distinguish the pathological condition from the physiological condition.
- 30 March 2023
- Published by Ministry of Health, Ankara City Hospital in Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi
- Vol. 20 (1) , 1612-1616
Evaluation of placental pathologies in cases of placenta previa
Objective: The primary aim of our study was to evaluate the underlying placental pathologies of placenta previa (PP). Materials and Methods: Over two years data of patients diagnosed to be PP in a tertiary center were obtained retrospectively. Routinely, the placentas of patients diagnosed to be PP were sent for pathological examination. Clinicodemographic data of the patients were recorded. The placental pathological findings were classified and evaluated in 5 main groups: maternal vascular lesions, fetal vascular lesions, inflammatory situations, umbilical cord findings, and normal. Additionally, complete blood count results at admission time for hospitalization and the outcomes of the neonates were recorded. Results: Thirty-two patients diagnosed to be PP were included in the study. The median age was 34 (22-42), and the median gravidity number was 3 (1-6). Maternal vascular lesions were observed in nearly half of the PP patients as a pathological finding (43.75 %). Inflammation was observed in 10 patients (31.25 %), umbilical cord findings in 8 patients (25.0 %), and fetal vascular lesions in 2 patients (6.25 %), respectively. 3 patients were reported to have normal placentas. In addition, the median neutrophile, neutrophile lymphocyte ratio, and white blood count were found to be high at admission time for hospitalization Conclusion: Maternal vascular lesions and inflammation were the most common detected placental pathological reports in PP patients. However, studies including the placentas of uncomplicated pregnancies will shed light on the literature to distinguish the pathological condition from the physiological condition.
- 13 March 2023
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 162 (2) , 737-743
Fetal neurosonography in pregnant women recovering from COVID‐19 disease
ObjectiveTo investigate the effect of severe acute respiratory virus 2 (SARS-CoV-2) on fetal neurodevelopment in pregnant women. MethodsThis prospective cohort study included 54 pregnant women at least 4 weeks after the SARS-CoV-2 infection and 58 controls. In the third trimester, the depths of the fetal insula, Sylvian, parieto-occipital, and calcarine fissures, the length of cavum septum pellucidum (CSP), and the thickness of the corpus callosum (CC) were measured. Sylvian fissure operculization and cortical development were graded. The correlation analysis between fetal cortical development and Sylvian fissure operculization was performed with the Pearson test. ResultsThe calcarine fissure depth and CC thickness were reduced in the study group (P < 0.001, P = 0.004). The fetal CSP length and ratio were increased in the study group (P = 0.016, P = 0.039). Approximately half of the study group fetuses had grade 4 or less Sylvian fissure operculization. The study group had a significantly higher rate of fetuses with grade 2 (31.5% vs. 13.8%) and significantly lower rate of fetuses with grade 4 cortical development (14.8% vs. 31.0%), compared with the controls. There was a moderate negative significant correlation between pregnant women recovering from COVID-19 and fetal cortical development and Sylvian fissure operculization (P = 0.001). ConclusionThis is the first study to investigate fetal cortical development in pregnant women recovering from COVID-19. The results indicate that COVID-19 disease may affect fetal neurodevelopment.
- 13 March 2023
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 162 (2) , 737-743
Fetal neurosonography in pregnant women recovering from COVID‐19 disease
ObjectiveTo investigate the effect of severe acute respiratory virus 2 (SARS-CoV-2) on fetal neurodevelopment in pregnant women. MethodsThis prospective cohort study included 54 pregnant women at least 4 weeks after the SARS-CoV-2 infection and 58 controls. In the third trimester, the depths of the fetal insula, Sylvian, parieto-occipital, and calcarine fissures, the length of cavum septum pellucidum (CSP), and the thickness of the corpus callosum (CC) were measured. Sylvian fissure operculization and cortical development were graded. The correlation analysis between fetal cortical development and Sylvian fissure operculization was performed with the Pearson test. ResultsThe calcarine fissure depth and CC thickness were reduced in the study group (P < 0.001, P = 0.004). The fetal CSP length and ratio were increased in the study group (P = 0.016, P = 0.039). Approximately half of the study group fetuses had grade 4 or less Sylvian fissure operculization. The study group had a significantly higher rate of fetuses with grade 2 (31.5% vs. 13.8%) and significantly lower rate of fetuses with grade 4 cortical development (14.8% vs. 31.0%), compared with the controls. There was a moderate negative significant correlation between pregnant women recovering from COVID-19 and fetal cortical development and Sylvian fissure operculization (P = 0.001). ConclusionThis is the first study to investigate fetal cortical development in pregnant women recovering from COVID-19. The results indicate that COVID-19 disease may affect fetal neurodevelopment.
- Open Access
- 13 March 2023
- Published by Wiley
Assessment Of Fetal Cardiac Functions In Pregnant Women Wı̇th Asthma
Aim:This study aims to investigate the effects of maternal asthma on fetal cardiac functions. Methods:The study was planned with 30 pregnant women who presented to a tertiary health center and were diagnosed with asthma and 60 healthy controls with similar gestational ages. The fetal echocardiographic assessment was assessed between 33 and 35 weeks of gestation with pulsed-wave Doppler (PW), M-mode, and tissue Doppler imaging (TDI). Fetal cardiac functions were compared between maternal asthma and control group. Cardiac functions were assessed according to the duration of maternal asthma diagnosis, as well. Results:Early diastolic function parameters, tricuspid E wave (p=0.001), and tricuspid E/A ratio (P=0.005) were significantly lower in the group with maternal asthma. TAPSE and MAPSE values were statistically lower in the study group than in the control group; p=0.010 and p=0.012, respectively. Parameters assessed with TDI (E’, A’, S’, E/E’, and MPI’ of tricuspid valves) and global cardiac function parameters assessed with pulsed-wave Doppler like myocardial performance index (MPI) and left cardiac output (LCO) were similar between groups (p> 0.05). Although, MPI did not change between groups, and the isovolumetric relaxation time (IVRT) value was prolonged in maternal asthma cases (p=0.025). Conclusion:We found that maternal asthma disease causes alteration in fetal diastolic and early systolic cardiac functions, but the global fetal cardiac function does not change. Diastolic heart function values also varied with the duration of maternal asthma. Prospective studies are needed to compare fetal cardiac functions with additional patient groups according to disease severity and type of medical treatment.
- 13 March 2023
- Published by Wiley
Open AccessAssessment Of Fetal Cardiac Functions In Pregnant Women Wı̇th Asthma
Aim:This study aims to investigate the effects of maternal asthma on fetal cardiac functions. Methods:The study was planned with 30 pregnant women who presented to a tertiary health center and were diagnosed with asthma and 60 healthy controls with similar gestational ages. The fetal echocardiographic assessment was assessed between 33 and 35 weeks of gestation with pulsed-wave Doppler (PW), M-mode, and tissue Doppler imaging (TDI). Fetal cardiac functions were compared between maternal asthma and control group. Cardiac functions were assessed according to the duration of maternal asthma diagnosis, as well. Results:Early diastolic function parameters, tricuspid E wave (p=0.001), and tricuspid E/A ratio (P=0.005) were significantly lower in the group with maternal asthma. TAPSE and MAPSE values were statistically lower in the study group than in the control group; p=0.010 and p=0.012, respectively. Parameters assessed with TDI (E’, A’, S’, E/E’, and MPI’ of tricuspid valves) and global cardiac function parameters assessed with pulsed-wave Doppler like myocardial performance index (MPI) and left cardiac output (LCO) were similar between groups (p> 0.05). Although, MPI did not change between groups, and the isovolumetric relaxation time (IVRT) value was prolonged in maternal asthma cases (p=0.025). Conclusion:We found that maternal asthma disease causes alteration in fetal diastolic and early systolic cardiac functions, but the global fetal cardiac function does not change. Diastolic heart function values also varied with the duration of maternal asthma. Prospective studies are needed to compare fetal cardiac functions with additional patient groups according to disease severity and type of medical treatment.